{"id":266943,"date":"2019-05-28T00:17:54","date_gmt":"2019-05-28T07:17:54","guid":{"rendered":"https:\/\/nai500.com\/?p=266943"},"modified":"2019-05-28T00:17:54","modified_gmt":"2019-05-28T07:17:54","slug":"%e4%bb%b7%e5%80%bc%e6%8a%95%e8%b5%84%ef%bc%9a%e6%8a%a4%e5%9f%8e%e6%b2%b3%e6%9c%80%e6%b7%b1%e6%9c%80%e5%ae%bd%e7%9a%843%e5%ae%b6%e5%a4%a7%e5%9e%8b%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e5%85%ac%e5%8f%b8","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/05\/%e4%bb%b7%e5%80%bc%e6%8a%95%e8%b5%84%ef%bc%9a%e6%8a%a4%e5%9f%8e%e6%b2%b3%e6%9c%80%e6%b7%b1%e6%9c%80%e5%ae%bd%e7%9a%843%e5%ae%b6%e5%a4%a7%e5%9e%8b%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e5%85%ac%e5%8f%b8\/","title":{"rendered":"\u4ef7\u503c\u6295\u8d44\uff1a\u62a4\u57ce\u6cb3\u6700\u6df1\u6700\u5bbd\u76843\u5bb6\u5927\u578b\u751f\u7269\u79d1\u6280\u516c\u53f8"},"content":{"rendered":"<p>\u4ef7\u503c\u6295\u8d44\u7684\u4e00\u5927\u903b\u8f91\u662f\u8003\u5bdf\u4e2a\u80a1\u7684\u62a4\u57ce\u6cb3\uff0c\u62a4\u57ce\u6cb3\u8d8a\u6df1\u8d8a\u5bbd\u7684\u516c\u53f8\uff0c\u5e02\u573a\u5730\u4f4d\u548c\u76c8\u5229\u80fd\u529b\u90fd\u66f4\u6709\u4fdd\u8bc1\u3002\u76f8\u6bd4\u4e4b\u4e0b\uff0c\u751f\u7269\u79d1\u6280\u80a1\u7684\u6700\u5927\u7279\u5f81\u662f\u4e0d\u786e\u5b9a\u6027\uff0c\u4f30\u503c\u6ca1\u6709\u4e0a\u9650\uff0c\u6ce2\u52a8\u4e5f\u5341\u5206\u660e\u663e\uff0c\u56e0\u6b64\u5f80\u5f80\u90fd\u96be\u5165\u8bf8\u5982\u5df4\u83f2\u7279\u8fd9\u7c7b\u4ef7\u503c\u578b\u6295\u8d44\u8005\u7684\u6cd5\u773c\u3002\u4e0d\u8fc7\uff0c\u51e1\u4e8b\u90fd\u6709\u4f8b\u5916\uff0c\u751f\u7269\u79d1\u6280\u9886\u57df\u5f53\u4e2d\u4e5f\u6709\u7eb5\u6df1\u9632\u5fa1\u5341\u5206\u5f3a\u5927\u7684\u516c\u53f8\u3002<\/p>\n<h4>Alexion Pharmaceuticals Inc\uff08NASDAQ: ALXN\uff09<\/h4>\n<p>\u5982\u679c\u4e00\u6b3e\u836f\u7269\u5c31\u5360\u636e\u4e86\u4e00\u5bb6\u751f\u7269\u79d1\u6280\u516c\u53f8\u6536\u5165\u7684\u7edd\u5927\u90e8\u5206\uff0c\u8fd9\u7edd\u5bf9\u662f\u4e00\u4e2a\u503c\u5f97\u8b66\u60d5\u7684\u4fe1\u53f7\u3002\u4e0d\u8fc7\uff0c\u8fd9\u4e00\u6cd5\u5219\u5e76\u4e0d\u9002\u7528\u4e8eAlexion\u3002\u8be5\u516c\u53f8\u53bb\u5e74\u603b\u6536\u5165\u4e3a$41\u4ebf\uff0c\u5176\u4e2dSoliris\u7684\u5360\u6bd4\u5c31\u8d85\u8fc7\u4e8686%\uff0c\u4f46\u6240\u5e78\u7684\u662f\uff0c\u8be5\u836f\u7269\u51e0\u4e4e\u6ca1\u6709\u7ade\u4e89\u5bf9\u624b\u3002<\/p>\n<p>2007\u5e74\uff0c\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7ba1\u5c40\uff08FDA\uff09\u9996\u6b21\u6279\u51c6Soliris\u6cbb\u7597\u9635\u53d1\u6027\u7761\u7720\u6027\u8840\u7ea2\u86cb\u767d\u5c3f\u75c7\uff08PNH\uff09\u3002\u5230\u76ee\u524d\u4e3a\u6b62\uff0c\u8fd9\u4ecd\u662f\u8fd9\u4e00\u6781\u5ea6\u7f55\u89c1\u9057\u4f20\u6027\u8840\u6db2\u75be\u75c5\u7684\u552f\u4e00\u83b7\u6279\u836f\u7269\u3002\u5728\u6b64\u540e2011\u5e74\u548c2017\u5e74\uff0cSoliris\u4e24\u79cd\u65b0\u7684\u9002\u5e94\u75c7\u2014\u2014\u975e\u5178\u578b\u6eb6\u8840\u6027\u5c3f\u6bd2\u7efc\u5408\u5f81\uff08aHUS\uff09\u4ee5\u53ca\u5168\u8eab\u578b\u91cd\u75c7\u808c\u65e0\u529b\uff08gMG\uff09\u2014\u2014\u4e5f\u5148\u540e\u83b7\u6279\u3002<\/p>\n<p>\u66f4\u4e3a\u53ef\u559c\u7684\u662f\uff0cAlexion\u53c8\u63a8\u51fa\u4e86\u65b0\u7684\u4ea7\u54c1Ultomiris\u3002\u8be5\u836f\u7269\u7684PNH\u9002\u5e94\u75c7\u5df2\u57282018\u5e7412\u6708\u83b7\u6279\uff0c\u65e9\u4e8e\u9884\u671f\u3002\u6b64\u5916\uff0caHUS\u9002\u5e94\u75c7\u6709\u671b\u5728\u4eca\u5e74\u83b7\u6279\u3002\u5e02\u573a\u7814\u7a76\u516c\u53f8EvaluatePharma\u5c06Ultomiris\u5217\u4e3a2019\u5e74\u7684\u6700\u5927\u65b0\u836f\uff0c\u5e76\u9884\u8ba1\u9500\u552e\u989d\u52302024\u5e74\u5c06\u9ad8\u8fbe$35\u4ebf\u3002<\/p>\n<h4>Biomarin Pharmaceutical Inc\uff08NASDAQ: BMRN\uff09<\/h4>\n<p>\u76f8\u8f83Alexion\uff0cBioMarin\u7684\u6536\u5165\u6765\u6e90\u66f4\u4e3a\u591a\u5143\uff0c\u4f46\u62a4\u57ce\u6cb3\u4e00\u6837\u5bbd\u6df1\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u6700\u7545\u9500\u7684\u4ea7\u54c1Vimizim\u53bb\u5e74\u521b\u6536\u5360\u5176\u603b\u6536\u5165\uff08$14.7\u4ebf\uff09\u7684\u8fd1\u4e09\u5206\u4e4b\u4e00\uff0c\u8be5\u836f\u7269\u662f\u9996\u4e2a\u4e5f\u662f\u552f\u4e00\u83b7\u6279\u7684\u7f55\u89c1\u9057\u4f20\u75c5Morquio A\u9176\u66ff\u4ee3\u7597\u6cd5\u3002<\/p>\n<p>\u82ef\u4e19\u916e\u5c3f\u75c7\uff08PKU\uff09\u6cbb\u7597\u836f\u7269Kuvan\u5360\u516c\u53f8\u603b\u6536\u5165\u7684\u6bd4\u91cd\u7ea6\u4e3a29%\uff0c\u7a0d\u6b21\u4e8eVimizim\u3002\u76ee\u524d\u8be5\u4ee3\u8c22\u75c5\u7684\u83b7\u6279\u5904\u65b9\u836f\u4ec5\u6709\u4e24\u79cd\u3002\u6392\u540d\u7b2c3\u7684Naglazyme\u662f\u9996\u4e2a\uff0c\u5e76\u4e14\u5230\u76ee\u524d\u4e3a\u6b62\u552f\u4e00\u83b7\u5f97FDA\u6279\u51c6\u7684\u6cbb\u7597\u7f55\u89c1\u9057\u4f20\u75c5\u2014\u2014VI\u578b\u9ecf\u591a\u7cd6\u75c5\uff08MPS VI\uff09\u2014\u2014\u7684\u9176\u66ff\u4ee3\u7597\u6cd5\u3002<\/p>\n<p>\u6b64\u5916\uff0cBioMarin\u7684\u5176\u4ed6\u836f\u7269\u4e5f\u62e5\u6709\u62a4\u57ce\u6cb3\u3002Aldurazyme\u662f\u552f\u4e00\u83b7\u6279\u7684MPS I\u6cbb\u7597\u624b\u6bb5\uff0cBrineura\u662f\u552f\u4e00\u83b7\u6279\u7684CLN2\u9176\u66ff\u4ee3\u7597\u6cd5\u3002\u53bb\u5e74\uff0cPalynziq\u83b7\u6279\u6cbb\u7597PKU\u3002<\/p>\n<h4>\u798f\u6cf0\u5236\u836fVertex Pharmaceuticals\uff08NASDAQ: VRTX\uff09<\/h4>\n<p>\u798f\u6cf0\u5236\u836f\u76ee\u524d\u4e0a\u5e02\u9500\u552e\u7684\u83b7\u6279\u4ea7\u54c1\u5206\u522b\u4e3aKalydeco\u3001Orkambi\u548cSymdeko\uff0c\u9002\u5e94\u75c7\u5747\u4e3a\u56ca\u80bf\u6027\u7ea4\u7ef4\u5316\uff08CF\uff09\uff0c\u5e76\u4e14\u8fd93\u79cd\u836f\u7269\u5747\u9488\u5bf9\u8be5\u75be\u75c5\u7684\u6839\u672c\u539f\u56e0\u3002<\/p>\n<p>\u6b64\u5916\uff0c\u798f\u6cf0\u5236\u836f\u5728\u4e0b\u4e00\u4ee3CF\u6cbb\u7597\uff08\u4e09\u8054\u7597\u6cd5\uff09\u9886\u57df\u4e5f\u5148\u4eba\u4e00\u6b65\u3002\u8be5\u751f\u7269\u79d1\u6280\u516c\u53f8\u9884\u8ba12019\u5e74\u4e09\u5b63\u5ea6\u5411FDA\u63d0\u4ea4\u9996\u4e2aCF\u4e09\u8054\u7597\u6cd5\u4e0a\u5e02\u7533\u8bf7\uff0c\u5e74\u5e95\u63d0\u4ea4\u6b27\u6d32\u7533\u8bf7\u3002\u827e\u4f2f\u7ef4AbbVie\uff08NYSE: ABBV\uff09\u7684CF\u4e09\u8054\u7597\u6cd5\u4e5f\u6709\u671b\u53d6\u5f97\u6210\u529f\uff0c\u4f46\u8fdb\u5ea6\u8fdc\u8fdc\u843d\u540e\u4e8e\u798f\u6cf0\u5236\u836f\u3002\u6b64\u5916\uff0c\u5728\u53bb\u5e74\u7684\u4e8c\u671f\u4e34\u5e8a\u7814\u7a76\u5f53\u4e2d\uff0c\u827e\u4f2f\u7ef4\u4e09\u8054\u7597\u6cd5\u5f53\u4e2d\u7684\u4e00\u6b3e\u5173\u952e\u836f\u7269\u5e76\u672a\u53d6\u5f97\u9884\u671f\u7684\u7ed3\u679c\u3002<\/p>\n<p>\u4e0e\u6b64\u540c\u65f6\uff0c\u798f\u6cf0\u5236\u836f\u8fd8\u6709\u671b\u8fdb\u519b\u5176\u4ed6\u9886\u57df\u5e76\u638c\u63e1\u65b0\u7684\u7eb5\u6df1\u9632\u5fa1\u3002\u516c\u53f8\u8054\u5408CRISPR Therapeutics AG\uff08NASDAQ: CRSP\uff09\u5f00\u53d1\u9488\u5bf9\u7f55\u89c1\u8840\u6db2\u75c5\u2014\u2014\u03b2-\u5730\u4e2d\u6d77\u8d2b\u8840\u4ee5\u53ca\u9570\u72b6\u7ec6\u80de\u75c5\u2014\u2014\u7684\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5\u3002\u6b64\u5916\uff0c\u516c\u53f8\u6b63\u5728\u8bc4\u4f30\u4e00\u6b3e\u5019\u9009\u836f\uff08\u521d\u671f\u4e34\u5e8a\u7814\u7a76\uff09\u6cbb\u7597\u7f55\u89c1\u9057\u4f20\u75c5\u2014\u2014\u03b11-\u6297\u80f0\u86cb\u767d\u9176\uff08AAT\uff09\u7f3a\u4e4f\u75c7\u2014\u2014\u7684\u6548\u679c\u3002<\/p>\n<h4>\u4f30\u503c\u6c34\u5e73<\/h4>\n<p>\u4f30\u503c\u65b9\u9762\uff0cBioMarin\u7684\u9884\u671f\u5e02\u76c8\u7387\u8d85\u8fc7320\u500d\uff0c\u5e76\u4e14\u8fc7\u53bb\u672a\u80fd\u5b9e\u73b0\u6301\u7eed\u76c8\u5229\u3002\u798f\u6cf0\u5236\u836f\u7684\u9884\u671f\u5e02\u76c8\u7387\u4e3a27\u500d\uff0c\u4e0d\u8fc7\u76f8\u8f83\u534e\u5c14\u8857\u5206\u6790\u5e08\u7ed9\u51fa\u7684\u672a\u67655\u5e7445%\u7684\u76c8\u5229\u5e74\u5747\u589e\u901f\u9884\u671f\uff0c\u8fd9\u4e00\u4f30\u503c\u6c34\u5e73\u5e76\u4e0d\u7b97\u9ad8\u3002\u76f8\u6bd4\u4e4b\u4e0b\uff0cAlexion\u7684\u9884\u671f\u5e02\u76c8\u7387\u8fd8\u4e0d\u523012\u500d\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4ef7\u503c\u6295\u8d44\u7684\u4e00\u5927\u903b\u8f91\u662f\u8003\u5bdf\u4e2a\u80a1\u7684\u62a4\u57ce\u6cb3\uff0c\u62a4\u57ce\u6cb3\u8d8a\u6df1\u8d8a\u5bbd\u7684\u516c\u53f8\uff0c\u5e02\u573a\u5730\u4f4d\u548c\u76c8\u5229\u80fd\u529b\u90fd\u66f4\u6709\u4fdd\u8bc1\u3002\u76f8\u6bd4\u4e4b\u4e0b\uff0c\u751f\u7269\u79d1\u6280\u80a1 [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":266945,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[430],"tags":[820,455,747,925,459],"class_list":["post-266943","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-trends-strategies-zh-hans","tag-820","tag-455","tag-747","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/266943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=266943"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/266943\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/266945"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=266943"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=266943"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=266943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}